​

Funding Round

Series B - Korro Bio

Series B - Korro Bio

Investment Firm

Overview

Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.

Announced Date

Jan 05, 2022

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

13

Investor Name
Participant InvestorPoint72
Participant InvestorInvus
Participant InvestorAtlas Venture
Participant InvestorNew Enterprise Associates
Participant InvestorFidelity

Round Details and Background

Korro Bio raised $116000000 on 2022-01-05 in Series B

Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 10, 2020
Series A - Korro Bio
8-91.5M
Jan 01, 2018
Seed Round - Korro Bio
2-undefined
Jan 05, 2022
Series B - Korro Bio
15-116.0M
Apr 18, 2024
Post-IPO Equity - Korro Bio
6-70.0M

Recent Activity

There is no recent news or activity for this profile.